Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 21.08B | 21.25B | 21.14B | 20.60B | 18.74B | 17.94B |
Gross Profit | 6.30B | 5.96B | 6.63B | 6.21B | 5.77B | 5.36B |
EBITDA | 2.16B | 2.01B | 2.78B | 2.30B | 1.88B | 1.85B |
Net Income | 1.33B | 1.12B | 1.74B | 1.40B | 1.07B | 1.03B |
Balance Sheet | ||||||
Total Assets | 26.18B | 26.56B | 24.63B | 20.91B | 19.28B | 17.72B |
Cash, Cash Equivalents and Short-Term Investments | 3.97B | 4.00B | 3.28B | 2.36B | 2.43B | 2.42B |
Total Debt | 3.66B | 3.51B | 2.59B | 1.06B | 675.63M | 674.20M |
Total Liabilities | 7.64B | 7.80B | 7.06B | 5.04B | 4.77B | 4.10B |
Stockholders Equity | 18.23B | 18.44B | 17.28B | 15.62B | 14.28B | 13.39B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 476.07M | 1.06B | -310.16M | 89.47M | 687.39M |
Operating Cash Flow | 0.00 | 1.47B | 1.43B | 308.73M | 1.32B | 924.59M |
Investing Cash Flow | 0.00 | -1.44B | -1.62B | -520.00M | -833.87M | -172.28M |
Financing Cash Flow | 0.00 | 642.50M | 1.07B | 117.00M | -523.35M | -644.87M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | ¥10.98B | 5.32 | 3.80% | -2.37% | -5.51% | ||
78 Outperform | ¥6.25B | 8.99 | 3.99% | 8.09% | 28.10% | ||
74 Outperform | ¥10.21B | 9.22 | 2.93% | 0.51% | -35.51% | ||
74 Outperform | ¥4.65B | 10.23 | 0.99% | 22.69% | 82.04% | ||
70 Neutral | ¥10.39B | 10.79 | 4.23% | 38.05% | 138.22% | ||
66 Neutral | ¥7.54B | 22.59 | 2.65% | 9.42% | -60.45% | ||
65 Neutral | $10.89B | 15.56 | 5.22% | 1.87% | 3.09% | -26.84% |